In acute myeloid leukemia (AML), specific genomic aberrations induce aberrant methylation, thus directly influencing the transcriptional programing of leukemic cells. Therefore, therapies targeting epigenetic processes are advocated as a promising therapeutic tool for AML treatment. However, to develop new therapies, a comprehensive understanding of the mechanism(s) driving the epigenetic changes as a result of acquired genetic abnormalities is necessary. This understanding is still lacking. In this study, we performed genome-wide CpG-island methylation profiling on pediatric AML samples. Six differentially methylated genomic regions within two genes, discriminating inv(16)(p13;q22) from non-inv(16) pediatric AML samples, were identified. All six regions had a hypomethylated phenotype in inv(16) AML samples, and this was most prominent at the regions encompassing the meningioma (disrupted in balanced translocation) 1 (MN1) oncogene. MN1 expression primarily correlated with the methylation level of the 3' end of the MN1 exon-1 locus. Decitabine treatment of different cell lines showed that induced loss of methylation at the MN1 locus can result in an increase of MN1 expression, indicating that MN1 expression is coregulated by DNA methylation. To investigate this methylation-associated mechanism, we determined the expression of DNA methyltransferases in inv(16) AML. We found that DNMT3B expression was significantly lower in inv(16) samples. Furthermore, DNMT3B expression correlated negatively with MN1 expression in pediatric AML samples. Importantly, depletion of DNMT3B impaired remethylation efficiency of the MN1 exon-1 locus in AML cells after decitabine exposure. These findings identify DNMT3B as an important coregulator of MN1 methylation. Taken together, this study shows that the methylation level of the MN1 exon-1 locus regulates MN1 expression levels in inv(16) pediatric AML. This methylation level is dependent on DNMT3B, thus suggesting a role for DNMT3B in leukemogenesis in inv(16) AML, through MN1 methylation regulation.

CHU de Paris Hôpital Robert Debré Paris France

Department of Pediatric Oncology Hematology Erasmus MC Sophia Children's Hospital Rotterdam The Netherlands

Department of Pediatric Oncology Hematology Medical High School Hannover Germany

Dutch Childhood Oncology Group The Hague The Netherlands

Pediatric Hematology Oncology 2nd Medical School Charles University Prague Czech Republic

Princess Maxima Center for Pediatric Oncology Utrecht The Netherlands

Zobrazit více v PubMed

N Engl J Med. 2010 Dec 16;363(25):2424-33 PubMed

Oncogene. 2006 Sep 21;25(42):5777-86 PubMed

Nat Rev Immunol. 2015 Jan;15(1):7-17 PubMed

Leukemia. 2007 Aug;21(8):1679-90 PubMed

J Clin Oncol. 2015 Sep 20;33(27):2949-62 PubMed

Nat Commun. 2016 Apr 28;7:11453 PubMed

Leukemia. 2013 Jul;27(7):1451-60 PubMed

Blood. 2007 Sep 1;110(5):1639-47 PubMed

Blood. 2006 Dec 1;108(12):3898-905 PubMed

Blood. 2006 Nov 15;108(10):3520-9 PubMed

Blood. 2009 Mar 26;113(13):3088-91 PubMed

Methods Mol Biol. 2002;200:87-100 PubMed

Leukemia. 1997 Sep;11(9):1447-52 PubMed

Blood. 2009 Jun 4;113(23):5951-60 PubMed

Epigenetics. 2011 Nov;6(11):1373-7 PubMed

Genes Dev. 2003 Sep 15;17(18):2298-307 PubMed

Blood. 2011 Nov 17;118(20):5573-82 PubMed

Haematologica. 2011 Feb;96(2):221-30 PubMed

Blood. 2008 Apr 15;111(8):4322-8 PubMed

PLoS One. 2012;7(3):e33213 PubMed

Blood. 2006 Sep 1;108(5):1690-7 PubMed

J Clin Invest. 2012 Jan;122(1):163-77 PubMed

Nat Rev Genet. 2008 Jun;9(6):465-76 PubMed

Sci Rep. 2015 Apr 22;5:9281 PubMed

Mol Cell Biol. 2002 Jan;22(2):480-91 PubMed

Cancer Cell. 2010 Jan 19;17(1):1-3 PubMed

Genes Immun. 2014 Mar;15(2):72-81 PubMed

Sci Rep. 2015 Jun 09;5:11126 PubMed

Neuropsychopharmacology. 2013 Jan;38(1):23-38 PubMed

J Clin Oncol. 2012 Apr 20;30(12):1350-7 PubMed

Blood Cells Mol Dis. 2007 Nov-Dec;39(3):336-9 PubMed

Leukemia. 2014 Sep;28(9):1774-83 PubMed

Hematology Am Soc Hematol Educ Program. 2011;2011:354-60 PubMed

Curr Biol. 2004 Nov 23;14(22):2063-9 PubMed

Cell Tissue Kinet. 1982 Jul;15(4):399-404 PubMed

Blood. 2009 Dec 24;114(27):5490-8 PubMed

Cancer. 2008 Aug 1;113(3):522-9 PubMed

Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W170-5 PubMed

PLoS One. 2010 Aug 16;5(8):e12197 PubMed

Br J Haematol. 2011 Oct;155(1):65-72 PubMed

N Engl J Med. 2004 Apr 15;350(16):1617-28 PubMed

Int J Oncol. 2010 May;36(5):1235-41 PubMed

Epigenetics. 2015;10(6):526-35 PubMed

Br J Cancer. 1994 Dec;70(6):1047-52 PubMed

Nature. 2002 Apr 4;416(6880):552-6 PubMed

Cancer Cell. 2010 Jan 19;17(1):13-27 PubMed

Blood. 2012 Oct 18;120(16):3187-205 PubMed

Mol Cell Biol. 2003 Aug;23(16):5594-605 PubMed

Nat Commun. 2012 Jun 26;3:923 PubMed

Leukemia. 2014 Apr;28(4):770-8 PubMed